Laurence Legros Selected Research

Laurence Legros Research Topics

Disease

32	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2023 - 04/2003
10	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 12/2005
7	Neoplasms (Cancer) 01/2024 - 11/2010
4	Multiple Myeloma 01/2019 - 07/2014
2	Thrombosis (Thrombus) 01/2024 - 11/2020
2	Leukemia 02/2023 - 01/2017
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 01/2017
2	Primary Myelofibrosis (Myelosclerosis) 01/2018 - 09/2013
2	Residual Neoplasm 01/2017 - 12/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2016 - 02/2011
2	Thrombocytopenia (Thrombopenia) 01/2015 - 02/2011
2	Neutropenia 01/2015 - 02/2011
1	Hepatitis 12/2023
1	Polycythemia (Erythrocytosis) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Drug-Related Side Effects and Adverse Reactions 01/2023
1	Pleural Effusion (Pleural Effusions) 01/2021
1	Splenomegaly 11/2020
1	Musculoskeletal Pain 11/2019
1	GATA2 Deficiency 01/2019
1	Weight Gain 01/2017
1	Anemia 01/2016
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2015
1	Down Syndrome (Down's Syndrome) 10/2014
1	Hyperplasia 10/2013
1	Lymphopenia (Lymphocytopenia) 02/2012
1	Hematologic Neoplasms (Hematological Malignancy) 02/2012
1	Blast Crisis (Blast Phase) 06/2011
1	Philadelphia Chromosome 02/2011
1	Bacteremia 02/2011
1	Infections 02/2011
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2011
1	Abnormal Karyotype 01/2011
1	Exanthema (Rash) 12/2010
1	Chromosome Aberrations (Chromosome Abnormalities) 09/2010
1	Pathologic Complete Response 05/2005
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 07/2004

Drug/Important Bio-Agent (IBA)

19	Imatinib Mesylate (Gleevec)FDA Link 12/2022 - 04/2003
18	Tyrosine Kinase InhibitorsIBA 12/2023 - 10/2010
7	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2012 - 04/2003
5	Proteins (Proteins, Gene)FDA Link 02/2023 - 07/2004
4	Azacitidine (5 Azacytidine)FDA Link 01/2019 - 01/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 07/2004
3	Dasatinib (BMS 354825)FDA Link 01/2021 - 10/2013
3	InterferonsIBA 01/2018 - 11/2010
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2011 - 04/2003
2	Hemoglobins (Hemoglobin)IBA 01/2024 - 01/2017
2	Oncogene Proteins (Oncogene Protein)IBA 12/2023 - 02/2016
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 02/2015
2	Lenalidomide (CC 5013)FDA Link 01/2019 - 04/2009
2	nilotinib FDA Link 01/2017 - 02/2016
2	HomoharringtonineIBA 05/2015 - 10/2010
2	Daunorubicin (Cerubidine)FDA LinkGeneric 06/2011 - 05/2005
2	bcr-abl Fusion ProteinsIBA 12/2003 - 04/2003
1	bosutinibIBA 12/2023
1	Adenosine Triphosphate (ATP)IBA 12/2023
1	alexidineIBA 02/2023
1	BiguanidesIBA 02/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023
1	lenvatinibIBA 01/2023
1	Protein Kinases (Protein Kinase)IBA 04/2021
1	Janus Kinase 2IBA 11/2020
1	Indicators and Reagents (Reagents)IBA 11/2020
1	C-Reactive ProteinIBA 11/2020
1	carfilzomibIBA 01/2019
1	guadecitabineIBA 01/2019
1	CytokinesIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017
1	Interferon-gamma (Interferon, gamma)IBA 01/2017
1	Pioglitazone (Actos)FDA Link 01/2017
1	Natural Killer Cell ReceptorsIBA 01/2017
1	guanosine 5'-monophosphorothioateIBA 01/2017
1	Protein Synthesis InhibitorsIBA 05/2015
1	pomalidomideIBA 02/2015
1	Uridine Diphosphate (UDP)IBA 01/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2015
1	LigandsIBA 01/2015
1	Alanine Transaminase (SGPT)IBA 01/2015
1	Amyloid (Amyloid Fibrils)IBA 10/2014
1	Melphalan (Alkeran)FDA LinkGeneric 07/2014
1	Bortezomib (Velcade)FDA Link 07/2012
1	PhytohemagglutininsIBA 02/2012
1	fas Receptor (CD95 Antigen)IBA 02/2012
1	Bevacizumab (Avastin)FDA Link 01/2012
1	GSK 1363089IBA 12/2011
1	Pyridinolcarbamate (P23)IBA 09/2011
1	liposomal doxorubicin (Doxil)FDA Link 02/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2011
1	peginterferon alfa-2a (Pegasys)FDA Link 12/2010
1	Arsenic Trioxide (Trisenox)FDA Link 06/2006
1	Thalidomide (Thalomid)FDA Link 12/2005

Therapy/Procedure

10	Therapeutics 01/2023 - 09/2010
2	Aftercare (After-Treatment) 12/2023 - 01/2018
2	Erythrocyte Transfusion 02/2011 - 06/2010
1	Stem Cell Transplantation 11/2010